503 related articles for article (PubMed ID: 30483271)
1. Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors.
Argyle D; Kitamura T
Front Immunol; 2018; 9():2629. PubMed ID: 30483271
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor-associated macrophage in tumor progression.
Fukuda K; Kobayashi A; Watabe K
Front Biosci (Schol Ed); 2012 Jan; 4(2):787-98. PubMed ID: 22202090
[TBL] [Abstract][Full Text] [Related]
3. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
[TBL] [Abstract][Full Text] [Related]
4. Clinical utilization of chemokines to combat cancer: the double-edged sword.
Dell'Agnola C; Biragyn A
Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375
[TBL] [Abstract][Full Text] [Related]
5. The chemokine network: a target in cancer biology?
Slettenaar VI; Wilson JL
Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages as targets for tumor immunotherapy.
Weigert A; Sekar D; Brüne B
Immunotherapy; 2009 Jan; 1(1):83-95. PubMed ID: 20635976
[TBL] [Abstract][Full Text] [Related]
9. Differential macrophage programming in the tumor microenvironment.
Ruffell B; Affara NI; Coussens LM
Trends Immunol; 2012 Mar; 33(3):119-26. PubMed ID: 22277903
[TBL] [Abstract][Full Text] [Related]
10. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
11. Distinct role of macrophages in different tumor microenvironments.
Lewis CE; Pollard JW
Cancer Res; 2006 Jan; 66(2):605-12. PubMed ID: 16423985
[TBL] [Abstract][Full Text] [Related]
12. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
13. Re-education of macrophages as a therapeutic strategy in cancer.
Kowal J; Kornete M; Joyce JA
Immunotherapy; 2019 Jun; 11(8):677-689. PubMed ID: 31088236
[TBL] [Abstract][Full Text] [Related]
14. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.
Lin Y; Xu J; Lan H
J Hematol Oncol; 2019 Jul; 12(1):76. PubMed ID: 31300030
[TBL] [Abstract][Full Text] [Related]
16. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Macrophages as Target for Antitumor Therapy.
Sawa-Wejksza K; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
[TBL] [Abstract][Full Text] [Related]
18. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
19. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
Nagarsheth N; Wicha MS; Zou W
Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
[TBL] [Abstract][Full Text] [Related]
20. Can we target the chemokine network for cancer therapeutics?
Giles R; Loberg RD
Curr Cancer Drug Targets; 2006 Dec; 6(8):659-70. PubMed ID: 17168671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
